Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry

To investigate in-hospital and long-term prognosis in T2DM patients presenting with acute myocardial infarction (AMI) treated with SGLT2-I versus other oral anti-diabetic agents (non-SGLT2-I users). In this multicenter international registry all consecutive diabetic AMI patients undergoing percutane...

Full description

Saved in:

Bibliographic Details
Published in:	Pharmacological research Vol. 187; p. 106597
Main Authors:	Paolisso, Pasquale, Bergamaschi, Luca, Gragnano, Felice, Gallinoro, Emanuele, Cesaro, Arturo, Sardu, Celestino, Mileva, Niya, Foà, Alberto, Armillotta, Matteo, Sansonetti, Angelo, Amicone, Sara, Impellizzeri, Andrea, Esposito, Giuseppe, Morici, Nuccia, Andrea, Oreglia Jacopo, Casella, Gianni, Mauro, Ciro, Vassilev, Dobrin, Galie, Nazzareno, Santulli, Gaetano, Marfella, Raffaele, Calabrò, Paolo, Pizzi, Carmine, Barbato, Emanuele
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier Ltd 01.01.2023
Subjects:	Acute Kidney Injury - etiology Acute myocardial infarction Arrhythmias Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - drug therapy HF hospitalization Humans Myocardial Infarction - drug therapy Outcomes Percutaneous Coronary Intervention - adverse effects Registries Risk Factors SGLT2-I Sodium-Glucose Transporter 2 Inhibitors - adverse effects Treatment Outcome NSTEMI T2DM HF hospitalization Outcomes SGLT2-I OAD PCI STEMI CABG Acute myocardial infarction AMI HF Arrhythmias RWMA
ISSN:	1043-6618, 1096-1186, 1096-1186
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!